GC Cell Inks 1st Licensing Agreement with Indian Firm

SEOUL, Jan. 4 (Korea Bizwire) — South Korean cell therapy developer GC Cell Corp. said Tuesday that it has signed the company’s first licensing agreement with India-based Rivaara Immune to develop its liver cancer treatment. Under the agreement, Rivaara Immune has obtained the exclusive right to develop and commercialize Immuncell-LC, immunotherapy for liver cancer, in [...]